Inducing stable reversion to achieve cancer control

Area of Science:

• Oncology and Cancer Research
• Molecular Biology
• Genetics

Background:

• Current cancer treatments focus on balancing tumor suppressor genes and oncogenes.
• Drug resistance arises from secondary mutations, posing a significant challenge to cancer therapy.
• Existing strategies often create selective pressure, leading to rapid treatment failure.

Approach:

• This opinion article advocates for a shift towards targeting tumor cell reversion.
• This strategy involves selecting and analyzing stable revertant cancer cells.
• The goal is to induce a less aggressive cellular state.

Key Points:

• Tumor cell reversion offers an alternative to directly combating mutations.
• By selecting for stable revertants, we can potentially bypass common resistance mechanisms.
• This approach aims to reduce the evolutionary pressure that fuels drug resistance.

Conclusions:

• Targeting tumor cell reversion could lead to more durable cancer remissions.
• This strategy may circumvent the issue of acquired drug resistance.
• A return to earlier therapeutic stratagems like reversion could revolutionize cancer treatment.